Daratumumab, lenalidomide, and dexamethasone combination in relapsed/refractory myeloma patients: a real-life single-center experience

被引：11

作者：

Antonioli, Elisabetta ^{[1
]}

Staderini, Michela ^{[1
]}

Pilerci, Sofia ^{[1
]}

Perfetto, Federico ^{[2
]}

Cappelli, Francesco ^{[2
]}

Allinovi, Marco ^{[2
,3
]}

Nozzoli, Chiara ^{[4
]}

Attucci, Irene ^{[1
]}

Buzzichelli, Alessandra ^{[1
]}

Messeri, Maria ^{[1
]}

Bosi, Alberto ^{[1
]}

机构：

[1] Careggi Univ Hosp, Haematol Unit, Largo Brambilla 3, I-50134 Florence, Italy

[2] Careggi Univ Hosp, Tuscan Reg Amyloidosis Ctr, Florence, Italy

[3] Careggi Hosp, Nephrol Dialysis & Transplantat Unit, Florence, Italy

[4] Careggi Univ Hosp, Cell Therapy & Transfus Med Unit, Florence, Italy

来源：

LEUKEMIA & LYMPHOMA | 2020年 / 61卷 / 13期

关键词：

REFRACTORY MULTIPLE-MYELOMA; MONOTHERAPY;

D O I：

10.1080/10428194.2020.1802452

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3255 / 3258

页数：4

共 14 条

[1] Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study [J].

Bahlis, Nizar J. ;

Dimopoulos, Meletios A. ;

White, Darrell J. ;

Benboubker, Lotfi ;

Cook, Gordon ;

Leiba, Merav ;

Ho, P. Joy ;

Kim, Kihyun ;

Takezako, Naoki ;

Moreau, Philippe ;

Kaufman, Jonathan L. ;

Krevvata, Maria ;

Chiu, Christopher ;

Qin, Xiang ;

Okonkwo, Linda ;

Trivedi, Sonali ;

Ukropec, Jon ;

Qi, Ming ;

San-Miguel, Jesus .

LEUKEMIA, 2020, 34 (07) :1875-1884

[2] Daratumumab Monotherapy in Heavily Pretreated Asian Patients With Relapsed and Refractory Multiple Myeloma: A Real-world Experience [J].

Byun, Ja Min ;

Yoon, Sung-Soo ;

Koh, Youngil ;

Kim, Inho ;

Jo, Jaemin ;

Park, Hyunkyung ;

Lee, Jeong-Ok ;

Lee, Jiyun .

ANTICANCER RESEARCH, 2019, 39 (09) :5165-5170

[3] Organ responses with daratumumab therapy in previously treated AL amyloidosis [J].

Chung, Alfred ;

Kaufman, Gregory P. ;

Sidana, Surbhi ;

Eckhert, Erik ;

Schrier, Stanley L. ;

Lafayette, Richard A. ;

Arai, Sally ;

Witteles, Ronald M. ;

Liedtke, Michaela .

BLOOD ADVANCES, 2020, 4 (03) :458-466

[4] Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors [J].

de Weers, Michel ;

Tai, Yu-Tzu ;

van der Veer, Michael S. ;

Bakker, Joost M. ;

Vink, Tom ;

Jacobs, Danielle C. H. ;

Oomen, Lukas A. ;

Peipp, Matthias ;

Valerius, Thomas ;

Slootstra, Jerry W. ;

Mutis, Tuna ;

Bleeker, Wim K. ;

Anderson, Kenneth C. ;

Lokhorst, Henk M. ;

van de Winkel, Jan G. J. ;

Parren, Paul W. H. I. .

JOURNAL OF IMMUNOLOGY, 2011, 186 (03) :1840-1848

[5] Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma [J].

Dimopoulos, M. A. ;

Oriol, A. ;

Nahi, H. ;

San-Miguel, J. ;

Bahlis, N. J. ;

Usmani, S. Z. ;

Rabin, N. ;

Orlowski, R. Z. ;

Komarnicki, M. ;

Suzuki, K. ;

Plesner, T. ;

Yoon, S. -S. ;

Ben Yehuda, D. ;

Richardson, P. G. ;

Goldschmidt, H. ;

Reece, D. ;

Lisby, S. ;

Khokhar, N. Z. ;

O'Rourke, L. ;

Chiu, C. ;

Qin, X. ;

Guckert, M. ;

Ahmadi, T. ;

Moreau, P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (14) :1319-1331

[6] Single-agent daratumumab in very advanced relapsed and refractory multiple myeloma patients: a real-life single-center retrospective study [J].

Jullien, Maxime ;

Trudel, Sabrina ;

Tessoulin, Benoit ;

Mahe, Beatrice ;

Dubruille, Viviane ;

Blin, Nicolas ;

Gastinne, Thomas ;

Bonnet, Antoine ;

Lok, Anne ;

Lebourgeois, Amandine ;

Peterlin, Pierre ;

Garnier, Alice ;

Chevalier, Patrice ;

Guillaume, Thierry ;

Thomare, Patrick ;

Le Gouill, Steven ;

Moreau, Philippe ;

Touzeau, Cyrille .

ANNALS OF HEMATOLOGY, 2019, 98 (06) :1435-1440

[7] Evaluation of the safety and efficacy of daratumumab outside of clinical trials [J].

Kobayashi, Hiroki ;

Tsushima, Takafumi ;

Terao, Toshiki ;

Abe, Yoshiaki ;

Miura, Daisuke ;

Narita, Kentaro ;

Kitadate, Akihiro ;

Takeuchi, Masami ;

Matsue, Kosei .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (06) :665-672

[8] Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial [J].

Lonial, Sagar ;

Weiss, Brendan M. ;

Usmani, Saad Z. ;

Singhal, Seema ;

Chari, Ajai ;

Bahlis, Nizar J. ;

Belch, Andrew ;

Krishnan, Amrita ;

Vescio, Robert A. ;

Victoria Mateos, Maria ;

Mazumder, Amitabha ;

Orlowski, Robert Z. ;

Sutherland, Heather J. ;

Blade, Joan ;

Scott, Emma C. ;

Oriol, Albert ;

Berdeja, Jesus ;

Gharibo, Mecide ;

Stevens, Don A. ;

LeBlanc, Richard ;

Sebag, Michael ;

Callander, Natalie ;

Jakubowiak, Andrzej ;

White, Darrell ;

de la Rubia, Javier ;

Richardson, Paul G. ;

Lisby, Steen ;

Feng, Huaibao ;

Uhlar, Clarissa M. ;

Khan, Imran ;

Ahmadi, Tahamtan ;

Voorhees, Peter M. .

LANCET, 2016, 387 (10027) :1551-1560

[9] Real-world data on the efficacy and safety of daratumumab treatment in Hungarian relapsed/refractory multiple myeloma patients [J].

Lovas, Szilvia ;

Varga, Gergely ;

Farkas, Peter ;

Masszi, Tamas ;

Wohner, Nikolett ;

Bereczki, Agnes ;

Adamkovich, Nora ;

Borbenyi, Zita ;

Szomor, Arpad ;

Alizadeh, Hussain ;

Szaleczky, Erika ;

Wolf, Krisztina ;

Schneider, Tamas ;

Plander, Mark ;

Szendrei, Tamas ;

Csacsovszki, Otto ;

Csukly, Zoltan ;

Rajnics, Peter ;

Egyed, Miklos ;

Nagy, Zsolt ;

Rejto, Laszlo ;

Illes, Arpad ;

Mikala, Gabor ;

Varoczy, Laszlo .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (05) :559-565

[10] Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma [J].

Overdijk, Marije B. ;

Verploegen, Sandra ;

Bogels, Marijn ;

van Egmond, Marjolein ;

van Bueren, Jeroen J. Lammerts ;

Mutis, Tuna ;

Groen, Richard W. J. ;

Breij, Esther ;

Martens, Anton C. M. ;

Bleeker, Wim K. ;

Parren, Paul W. H. I. .

MABS, 2015, 7 (02) :311-320

← 1 2 →